Cargando…

Distinguishing Binders from False Positives by Free Energy Calculations: Fragment Screening Against the Flap Site of HIV Protease

[Image: see text] Molecular docking is a powerful tool used in drug discovery and structural biology for predicting the structures of ligand–receptor complexes. However, the accuracy of docking calculations can be limited by factors such as the neglect of protein reorganization in the scoring functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Nanjie, Forli, Stefano, He, Peng, Perryman, Alex, Wickstrom, Lauren, Vijayan, R. S. K., Tiefenbrunn, Theresa, Stout, David, Gallicchio, Emilio, Olson, Arthur J., Levy, Ronald M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306491/
https://www.ncbi.nlm.nih.gov/pubmed/25189630
http://dx.doi.org/10.1021/jp506376z
_version_ 1782354331261992960
author Deng, Nanjie
Forli, Stefano
He, Peng
Perryman, Alex
Wickstrom, Lauren
Vijayan, R. S. K.
Tiefenbrunn, Theresa
Stout, David
Gallicchio, Emilio
Olson, Arthur J.
Levy, Ronald M.
author_facet Deng, Nanjie
Forli, Stefano
He, Peng
Perryman, Alex
Wickstrom, Lauren
Vijayan, R. S. K.
Tiefenbrunn, Theresa
Stout, David
Gallicchio, Emilio
Olson, Arthur J.
Levy, Ronald M.
author_sort Deng, Nanjie
collection PubMed
description [Image: see text] Molecular docking is a powerful tool used in drug discovery and structural biology for predicting the structures of ligand–receptor complexes. However, the accuracy of docking calculations can be limited by factors such as the neglect of protein reorganization in the scoring function; as a result, ligand screening can produce a high rate of false positive hits. Although absolute binding free energy methods still have difficulty in accurately rank-ordering binders, we believe that they can be fruitfully employed to distinguish binders from nonbinders and reduce the false positive rate. Here we study a set of ligands that dock favorably to a newly discovered, potentially allosteric site on the flap of HIV-1 protease. Fragment binding to this site stabilizes a closed form of protease, which could be exploited for the design of allosteric inhibitors. Twenty-three top-ranked protein–ligand complexes from AutoDock were subject to the free energy screening using two methods, the recently developed binding energy analysis method (BEDAM) and the standard double decoupling method (DDM). Free energy calculations correctly identified most of the false positives (≥83%) and recovered all the confirmed binders. The results show a gap averaging ≥3.7 kcal/mol, separating the binders and the false positives. We present a formula that decomposes the binding free energy into contributions from the receptor conformational macrostates, which provides insights into the roles of different binding modes. Our binding free energy component analysis further suggests that improving the treatment for the desolvation penalty associated with the unfulfilled polar groups could reduce the rate of false positive hits in docking. The current study demonstrates that the combination of docking with free energy methods can be very useful for more accurate ligand screening against valuable drug targets.
format Online
Article
Text
id pubmed-4306491
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-43064912015-09-05 Distinguishing Binders from False Positives by Free Energy Calculations: Fragment Screening Against the Flap Site of HIV Protease Deng, Nanjie Forli, Stefano He, Peng Perryman, Alex Wickstrom, Lauren Vijayan, R. S. K. Tiefenbrunn, Theresa Stout, David Gallicchio, Emilio Olson, Arthur J. Levy, Ronald M. J Phys Chem B [Image: see text] Molecular docking is a powerful tool used in drug discovery and structural biology for predicting the structures of ligand–receptor complexes. However, the accuracy of docking calculations can be limited by factors such as the neglect of protein reorganization in the scoring function; as a result, ligand screening can produce a high rate of false positive hits. Although absolute binding free energy methods still have difficulty in accurately rank-ordering binders, we believe that they can be fruitfully employed to distinguish binders from nonbinders and reduce the false positive rate. Here we study a set of ligands that dock favorably to a newly discovered, potentially allosteric site on the flap of HIV-1 protease. Fragment binding to this site stabilizes a closed form of protease, which could be exploited for the design of allosteric inhibitors. Twenty-three top-ranked protein–ligand complexes from AutoDock were subject to the free energy screening using two methods, the recently developed binding energy analysis method (BEDAM) and the standard double decoupling method (DDM). Free energy calculations correctly identified most of the false positives (≥83%) and recovered all the confirmed binders. The results show a gap averaging ≥3.7 kcal/mol, separating the binders and the false positives. We present a formula that decomposes the binding free energy into contributions from the receptor conformational macrostates, which provides insights into the roles of different binding modes. Our binding free energy component analysis further suggests that improving the treatment for the desolvation penalty associated with the unfulfilled polar groups could reduce the rate of false positive hits in docking. The current study demonstrates that the combination of docking with free energy methods can be very useful for more accurate ligand screening against valuable drug targets. American Chemical Society 2014-09-05 2015-01-22 /pmc/articles/PMC4306491/ /pubmed/25189630 http://dx.doi.org/10.1021/jp506376z Text en Copyright © 2014 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Deng, Nanjie
Forli, Stefano
He, Peng
Perryman, Alex
Wickstrom, Lauren
Vijayan, R. S. K.
Tiefenbrunn, Theresa
Stout, David
Gallicchio, Emilio
Olson, Arthur J.
Levy, Ronald M.
Distinguishing Binders from False Positives by Free Energy Calculations: Fragment Screening Against the Flap Site of HIV Protease
title Distinguishing Binders from False Positives by Free Energy Calculations: Fragment Screening Against the Flap Site of HIV Protease
title_full Distinguishing Binders from False Positives by Free Energy Calculations: Fragment Screening Against the Flap Site of HIV Protease
title_fullStr Distinguishing Binders from False Positives by Free Energy Calculations: Fragment Screening Against the Flap Site of HIV Protease
title_full_unstemmed Distinguishing Binders from False Positives by Free Energy Calculations: Fragment Screening Against the Flap Site of HIV Protease
title_short Distinguishing Binders from False Positives by Free Energy Calculations: Fragment Screening Against the Flap Site of HIV Protease
title_sort distinguishing binders from false positives by free energy calculations: fragment screening against the flap site of hiv protease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306491/
https://www.ncbi.nlm.nih.gov/pubmed/25189630
http://dx.doi.org/10.1021/jp506376z
work_keys_str_mv AT dengnanjie distinguishingbindersfromfalsepositivesbyfreeenergycalculationsfragmentscreeningagainsttheflapsiteofhivprotease
AT forlistefano distinguishingbindersfromfalsepositivesbyfreeenergycalculationsfragmentscreeningagainsttheflapsiteofhivprotease
AT hepeng distinguishingbindersfromfalsepositivesbyfreeenergycalculationsfragmentscreeningagainsttheflapsiteofhivprotease
AT perrymanalex distinguishingbindersfromfalsepositivesbyfreeenergycalculationsfragmentscreeningagainsttheflapsiteofhivprotease
AT wickstromlauren distinguishingbindersfromfalsepositivesbyfreeenergycalculationsfragmentscreeningagainsttheflapsiteofhivprotease
AT vijayanrsk distinguishingbindersfromfalsepositivesbyfreeenergycalculationsfragmentscreeningagainsttheflapsiteofhivprotease
AT tiefenbrunntheresa distinguishingbindersfromfalsepositivesbyfreeenergycalculationsfragmentscreeningagainsttheflapsiteofhivprotease
AT stoutdavid distinguishingbindersfromfalsepositivesbyfreeenergycalculationsfragmentscreeningagainsttheflapsiteofhivprotease
AT gallicchioemilio distinguishingbindersfromfalsepositivesbyfreeenergycalculationsfragmentscreeningagainsttheflapsiteofhivprotease
AT olsonarthurj distinguishingbindersfromfalsepositivesbyfreeenergycalculationsfragmentscreeningagainsttheflapsiteofhivprotease
AT levyronaldm distinguishingbindersfromfalsepositivesbyfreeenergycalculationsfragmentscreeningagainsttheflapsiteofhivprotease